These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17938752)

  • 1. Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent.
    Wöhrle J; Nusser T; Krause BJ; Kochs M; Habig T; Mottaghy FM; Kestler HA; Hombach V; Reske SN
    Nuklearmedizin; 2007; 46(5):185-91. PubMed ID: 17938752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
    Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
    Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-year clinical follow-up after treatment of diffuse in-stent restenosis with cutting balloon angioplasty followed by intracoronary brachytherapy with liquid rhenium-188-filled balloon via transradial approach.
    Hang CL; Hsieh BT; Wu CJ; Yip HK; Yang CH; Chen SM; Hsieh YK; Fu M; Chua S; Guo GB; Leung SW
    Circ J; 2011; 75(1):113-20. PubMed ID: 21139252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesions.
    Höher M; Wöhrle J; Wohlfrom M; Kamenz J; Nusser T; Grebe OC; Hanke H; Kochs M; Reske SN; Hombach V; Kotzerke J
    Circulation; 2003 Jun; 107(24):3022-7. PubMed ID: 12796137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
    Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
    Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
    Werner GS; Krack A; Schwarz G; Prochnau D; Betge S; Figulla HR
    J Am Coll Cardiol; 2004 Dec; 44(12):2301-6. PubMed ID: 15607390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass grafts.
    Wöhrle J; Krause BJ; Nusser T; Mottaghy FM; Habig T; Kochs M; Kotzerke J; Reske SN; Hombach V; Höher M
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1314-20. PubMed ID: 16791596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    Circulation; 2004 Apr; 109(16):1942-7. PubMed ID: 15078803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).
    Wong SC; Hong MK; Ellis SG; Buchbinder M; Reisman M; DeLago A; Kellett M; Popma JJ; Russell ME; Mehran R; Moses JW; Stone GW
    Am J Cardiol; 2005 May; 95(9):1043-8. PubMed ID: 15842968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.
    Grube E; Silber S; Hauptmann KE; Mueller R; Buellesfeld L; Gerckens U; Russell ME
    Circulation; 2003 Jan; 107(1):38-42. PubMed ID: 12515740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
    Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
    Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.